Sanjivani Paranteral Limited (BOM:531569)
203.85
+8.40 (4.30%)
At close: Feb 12, 2026
Sanjivani Paranteral Revenue
Sanjivani Paranteral had revenue of 154.97M INR in the quarter ending September 30, 2025, a decrease of -14.53%. This brings the company's revenue in the last twelve months to 689.20M, up 10.46% year-over-year. In the fiscal year ending March 31, 2025, Sanjivani Paranteral had annual revenue of 700.99M with 28.83% growth.
Revenue (ttm)
689.20M
Revenue Growth
+10.46%
P/S Ratio
3.75
Revenue / Employee
17.23M
Employees
40
Market Cap
2.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 700.99M | 156.88M | 28.83% |
| Mar 31, 2024 | 544.11M | 189.19M | 53.31% |
| Mar 31, 2023 | 354.92M | 48.79M | 15.94% |
| Mar 31, 2022 | 306.13M | 55.13M | 21.96% |
| Mar 31, 2021 | 251.00M | 87.44M | 53.46% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZIM Laboratories | 3.79B |
| Ambalal Sarabhai Enterprises | 1.97B |
| Sat Kartar Shopping | 1.63B |
| Gennex Laboratories | 1.49B |
| Trident Lifeline | 1.27B |
| Kerala Ayurveda | 1.26B |
| Oxygenta Pharmaceutical | 1.13B |
| Aayush Wellness | 1.11B |
Sanjivani Paranteral News
- 3 months ago - Q2 2026 Sanjivani Paranteral Ltd Earnings Call Transcript - GuruFocus